Table V.
95% confidence interval | ||||||||
---|---|---|---|---|---|---|---|---|
Groups | Factors | RC | SE | Wald | P | RR | Lower | Upper |
Pathological types | SC/ASC | 0.108 | 0.360 | 0.090 | 0.764 | 1.114 | 0.550 | 2.256 |
Differatiation | Well/moderately/poorly | 1.100 | 0.399 | 7.600 | 0.006 | 3.004 | 1.374 | 6.567 |
Tumor mass size | ≤3/>3 cm | 2.351 | 0.791 | 8.834 | 0.003 | 10.496 | 2.227 | 49.470 |
Gallstone | No/yes | 0.859 | 0.479 | 3.216 | 0.073 | 2.361 | 0.923 | 6.037 |
TNM stage | I+II/III/IV | 1.252 | 0.518 | 5.842 | 0.016 | 3.497 | 1.267 | 9.653 |
Lymph metastasis | No/yes | 1.180 | 0.473 | 6.224 | 0.013 | 3.254 | 1.288 | 8.224 |
Invasion | No/yes | 2.624 | 0.809 | 10.520 | 0.001 | 13.791 | 2.825 | 67.332 |
Surgery | Radical/palliative/biopsy | 1.084 | 0.467 | 5.388 | 0.020 | 2.956 | 1.184 | 7.384 |
MCM2 | −/+ | 1.136 | 0.488 | 5.419 | 0.020 | 3.114 | 1.197 | 8.105 |
TIP30 | −/+ | −0.981 | 0.470 | 4.357 | 0.037 | 0.375 | 0.149 | 0.942 |
SC, squamous cell; ASC, adenosquamous carcinoma; RC, regression coefficients; SE, standard error; RR, relative risk; MCM2, minichromosome maintenance complex component 2; TIP30, HIV-1 tat interactive protein 2.